Pirfenidone

FDA Approved: * June 9, 2023
Pharm Company: * APOTEX INC
Category: Lungs (Pulmonary)

Pirfenidone is a medication used for the treatment of idiopathic pulmonary fibrosis. It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II. It was first approved in Japan for the treatment of patients with idiopathic pulmonary fibrosis after clinical trials, under the trade name of Pirespa by Shionogi, in 2008. It was approved for use in the European Union in 2011,[2][3] in Canada in 2012, and in... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Pirfenidone 267 mg Oral Tablet, Film Coated
NDC: 0480-3610
Labeler:
Teva Pharmaceuticals, Inc.
Pirfenidone 801 mg Oral Tablet, Film Coated
NDC: 0480-3611
Labeler:
Teva Pharmaceuticals, Inc.
Pirfenidone 267 mg Oral Capsule
NDC: 0781-2158
Labeler:
Sandoz Inc
Pirfenidone 267 mg Oral Tablet, Film Coated
NDC: 0781-8085
Labeler:
Sandoz Inc
Pirfenidone 801 mg Oral Tablet, Film Coated
NDC: 0781-8086
Labeler:
Sandoz Inc
Pirfenidone 267 mg Oral Tablet, Film Coated
NDC: 0904-7397
Labeler:
Major Pharmaceuticals
Pirfenidone 801 mg Oral Tablet, Film Coated
NDC: 0904-7398
Labeler:
Major Pharmaceuticals
Pirfenidone 267 mg Oral Tablet, Film Coated
NDC: 16729-467
Labeler:
Accord Healthcare Inc.
Pirfenidone 801 mg Oral Tablet, Film Coated
NDC: 16729-468
Labeler:
Accord Healthcare Inc.
Pirfenidone 267 mg Oral Tablet, Film Coated
NDC: 31722-872
Labeler:
Camber Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients